卵泡抑素对肿瘤恶病质小鼠骨骼肌消耗的影响及其作用机制

doi:10.13481/j.1671-587x.20160404

吉林大学学报(医学版) ›› 2016, Vol. 42 ›› Issue (04): 653-658.doi: 10.13481/j.1671-587x.20160404

卵泡抑素对肿瘤恶病质小鼠骨骼肌消耗的影响及其作用机制

王朝义¹, 王强¹, 郑曰勇¹, 李聪², 郭敦伟¹, 唐华¹

1. 重庆医科大学附属第一医院胃肠外科, 重庆 400016;
2. 重庆医科大学附属第一医院妇科, 重庆 400016

收稿日期:2015-06-07 发布日期:2016-07-20
通讯作者: 唐华,副教授,硕士研究生导师(Tel:023-89011172,E-mail:tanglihua6969@sina.com) E-mail:tanglihua6969@sina.com
作者简介:王朝义(1989-),男,重庆市人,在读医学硕士,主要从事肿瘤恶病质的防治及其分子机制方面的研究。
基金资助:
国家自然科学基金资助课题（81100399）

Effect of follistatin on skeletal muscle wasting of cancer cachexia mice and its mechanism

WANG Chaoyi¹, WANG Qiang¹, ZHENG Yueyong¹, LI Cong², GUO Dunwei¹, TANG Hua¹

1. Department of Gastrointestinal Surgery, First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China;
2. Department of Gynaecology, First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China

Received:2015-06-07 Published:2016-07-20

摘要/Abstract

摘要：

目的：观察卵泡抑素（FST）对肿瘤恶病质小鼠骨骼肌消耗及肌肉生长抑制素（Mstn）、长链非编码RNA（LncRNA）-肺癌转移相关转录本1（MALAT1）和Caspase-3表达的影响，阐明其缓解肿瘤恶病质小鼠骨骼肌消耗的可能机制。方法：32只BALB/c小鼠随机分为健康对照组（HC组）、FST预防组（FP组）、FST治疗组（FT组）和肿瘤恶病质组（CC组），每组8只，后3组小鼠皮下接种小鼠结肠癌CT26细胞诱导肿瘤恶病质。监测各组小鼠体质量、自发性活动量和肿瘤生长情况。于接种后第6、12天FP和FT组小鼠分别给予FST（5 μg· kg^-1·d^-1）腹腔注射。第20天采集标本，称肿瘤及腓肠肌质量，检测小鼠血清生化代谢指标及腓肠肌纤维横切面积，Real-time PCR法检测小鼠腓肠肌和肿瘤组织中Mstn、Caspase-3及LncRNA-MALAT1 mRNA表达水平，Western blotting法检测小鼠腓肠肌组织中Mstn和Caspase-3蛋白表达水平。结果：与CC组比较，FP和FT组小鼠体质量、自发性活动量、腓肠肌质量及其肌纤维横切面积均增加（P < 0.05），生化代谢指标改善（P < 0.05）。与HC组比较，CC组小鼠腓肠肌组织中Mstn和Caspase-3 mRNA及蛋白表达水平均升高（P < 0.05），LncRNA-MALAT1 mRNA表达水平降低（P < 0.05）；与CC组比较，FP和FT组小鼠腓肠肌组织中Mstn和Caspase-3 mRNA及蛋白表达水平均降低（P < 0.05），LncRNA-MALAT1mRNA表达水平升高（P < 0.05），且FP组预防效果优于FT组（P < 0.05）。结论：FST可缓解肿瘤恶病质小鼠骨骼肌消耗，其机制可能与抑制Mstn表达、上调LncRNA-MALAT1表达从而降低Caspase-3表达有关。

关键词: 肿瘤恶病质, 卵泡抑素, 肌肉生长抑制素, 长链非编码RNA, 肺癌转移相关转录本1

Abstract:

Objective: To observe the effects of follistatin(FST) on the skeletal muscle wasting of cancer cachexia mice and the expressions of Mstn,LncRNA-MALAT1 and Caspase-3,and to elucidate its associated molecular mechanisms. Methods: Thirty-two BALB/c mices were randomly assigned into:healthy control (HC) group,FST prevention (FP) group,FST treatment (FT) group and cancer cachexia(CC) group.The murine colon adenocarcinoma CT26 cells were inoculated subcutaneously into the mices in FP,FT and CC groups to establish the cancer cachexia models.The body weight,spontaneous activity and tumor growth were daily monitored.The mice in FP and FT groups were administrated with FST intraperitoneally on day 6 and 12 after inoculation.The samples were collected on day 20. The tumor and gastrocnemius weights of the mice were detected.The biochemical metabolism indexes and myofiber cross-sectional area of gastrocnemius tissue were detected. The mRNA expression levels of Mstn,Caspase-3 and LncRNA-MALAT1 were examined by Real-time PCR. The protein expression levels of Mstn and Caspase-3 were measured by Western blotting method. Results: Compared with CC group,the body weights,spontaneous activities,gastrocnemius weights and myofiber cross-sectional areas were increased(P < 0.05); the serum levels of glucose,total protein and albumin of the mice in FP and FT groups were increased (P < 0.05). The protein and mRNA expression levels of Mstn and Caspase-3 in gastrocnemius of the mice in CC group were significantly higher and the expression level of LncRNA-MALAT1 was significantly lower than those in HC group(P < 0.05).The mRNA and protein expression levels of Mstn and Caspase-3 in FP and FT groups were reduced and the expression level of LncRNA-MALAT1 was increased compared with CC group(P < 0.05).The prevention effect in FP group is better than FT group(P < 0.05). Conclusion: FST may alleviate the muscle wasting of the mice with cancer cachexia by inhibiting the expression of Mstn,thus upregulating the expression of LncRNA-MALAT1 which in turn to suppress the expression of Caspase-3.

Key words: cancer cachexia, follistatin, myostatin, long non-coding RNA, metastasis-associated lung adenocarcinoma transcript1

中图分类号:

R730.5

王朝义, 王强, 郑曰勇, 李聪, 郭敦伟, 唐华. 卵泡抑素对肿瘤恶病质小鼠骨骼肌消耗的影响及其作用机制[J]. 吉林大学学报(医学版), 2016, 42(04): 653-658.

WANG Chaoyi, WANG Qiang, ZHENG Yueyong, LI Cong, GUO Dunwei, TANG Hua. Effect of follistatin on skeletal muscle wasting of cancer cachexia mice and its mechanism[J]. Journal of Jilin University Medicine Edition, 2016, 42(04): 653-658.

参考文献

[1] Fearon K,Strasser F,Anker SD,et al.Definition and classification of cancer cachexia:an international consensus[J].Lancet Oncol,2011,12(5):489-495.

[2] Tisdale MJ. Cancer cachexia[J]. Anticancer Drugs,1993,4(2):115-125.

[3] 薛鹏,陶钧,赵晖,等.Myostatin基因在荷瘤裸鼠腓肠肌组织中的表达[J].上海交通大学学报:医学版,2006,26(10):1143-1146.

[4] Gallot YS,Durieux AC,Castells J,et al. Myostatin gene inactivation prevents skeletal muscle wasting in cancer[J]. Cancer Res,2014,74(24):7344-7356.

[5] Thissen JP,Loumaye A. Role of Activin A and Myostatin in cancer cachexia[J]. Ann Endocrinol (Paris),2013,74(2):79-81.

[6] Watts R,Johnsen VL,Shearer J,et al. Myostatin-induced inhibition of the long noncoding RNA Malat1 is associated with decreased myogenesis[J]. Am J Physiol Cell Physiol,2013,304(10):C995-1001.

[7] Guo F,Li Y,Liu Y,et al. Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion[J]. Acta Biochim Biophys Sin (Shanghai),2010,42(3):224-229.

[8] Du J,Wang X,Miereles C,et al. Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions[J]. J Clin Invest,2004,113(1):115-123.

[9] Lee SJ,Lee YS,Zimmers TA,et al. Regulation of muscle mass by follistatin and activins[J]. Mol Endocrinol,2010,24(10):1998-2008.

[10] Aulino P,Berardi E,Cardillo VM,et al. Molecular,cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse[J]. BMC Cancer,2010,10:363.

[11] Han HQ,Mitch WE. Targeting the myostatin signaling pathway to treat muscle wasting diseases[J]. Curr Opin Support Palliat Care,2011,5(4):334-341.

[12] Ji P,Diederichs S,Wang W,et al. MALAT-1,a novel noncoding RNA,and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer[J]. Oncogene,2003,22(39):8031-8041.

[13] Tripathi V,Ellis JD,Shen Z,et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation[J]. Mol Cell,2010,39(6):925-938.

[14] Änkö ML,Müller-McNicoll M,Brandl H,et al. The RNA-binding landscapes of two SR proteins reveal unique functions and binding to diverse RNA classes[J]. Genome Biol,2012,13(3):R17.

[15] Han X,Yang F,Cao H,et al. Malat1 regulates serum response factor through miR-133 as a competing endogenous RNA in myogenesis[J]. FASEB J,2015,29(7):3054-3064.

[16] Iizuka K,Machida T,Hirafuji M.Skeletal muscle is an endocrine organ[J]. J Pharmacol Sci,2014,125(2):125-131.

卵泡抑素对肿瘤恶病质小鼠骨骼肌消耗的影响及其作用机制

Effect of follistatin on skeletal muscle wasting of cancer cachexia mice and its mechanism

RichHTML

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 4

Metrics

本文评价

推荐阅读 10

[1]	黄琦, 沙辉, 陈龙, 吕龙龙, 徐声鸣, 张泽天, 赵松, 靳凤艳, 牛丰. 多发性骨髓瘤和慢性淋巴细胞白血病患者血浆lncRNA MALAT1、LincRNA-p21和GAS5的表达水平及其诊断意义[J]. 吉林大学学报(医学版), 2018, 44(02): 339-345.
[2]	刘相良, 袁铭成, 纪伟, 徐鑫宇, 梅起腾, 李理, 陈晓, 李薇. 长链非编码RNA在肺癌发生发展中作用的研究进展[J]. 吉林大学学报(医学版), 2017, 43(02): 450-453.
[3]	郑曰勇1，刘红2，李聪3，王强1，唐华1. Caspase-3在小鼠肿瘤恶病质肌肉蛋白消耗中的作用[J]. 吉林大学学报(医学版), 2014, 40(04): 710-714.
[4]	袁婷\|刘帅\|李小平\|唐成程\|韩晓蕾\|逄大欣\|欧阳红生. 骨骼肌特异性表达猪FSⅠ-Ⅰ转基因猪胚胎成纤维细胞克隆的构建与鉴定[J]. J4, 2012, 38(2): 192-196.